In 5 clinical trials, 1338 adult patients received this drug.  The most common side effects were anemia, headache, nausea, diarrhea, rash, elevated hepatic enzymes, and phlebitis.  During clinical studies, this drug was discontinued due to side effects in 4.1% of patients.
Very common (10% or more): Headache (up to 16%)Frequency not reported: DizzinessPostmarketing reports: Seizure
Very common (10% or more): Nausea (up to 12%), diarrhea (up to 12%)Common (1% to 10%): Oral candidiasisUncommon (0.1% to 1%): Clostridium difficile colitisFrequency not reported: Constipation, abdominal pain, dyspepsia
Frequency not reported: Hypersensitivity reactionsPostmarketing reports: Anaphylaxis
Serious and sometimes fatal hypersensitivity (anaphylactic) reactions have been reported with beta-lactams.
Common (1% to 10%): AnemiaPostmarketing reports: Neutropenia, leukopenia, thrombocytopenia
Common (1% to 10%): PhlebitisFrequency not reported: Atrial fibrillation, atrial flutter, hypertension, hypotension
Elevated hepatic enzymes also included ALT or AST at or below the upper limit of normal (ULN) at baseline increasing to greater than 5 times ULN at end of therapy.
Common (1% to 10%): Elevated hepatic enzymes (includes elevated ALT, elevated AST, elevated transaminases)Frequency not reported: Cholestasis
Common (1% to 10%): Rash, pruritusFrequency not reported: Erythema, macular/papular eruptions, bullous dermatitis, urticaria, erythema multiforme, allergic dermatitis, decubitus ulcerPostmarketing reports: Stevens-Johnson syndrome, toxic epidermal necrolysis
The incidence of rash was higher in patients receiving doses greater than the approved dose compared to those receiving the approved dose.  The rash resolved within 10 days after this drug was stopped.Serious skin reactions have been reported with beta-lactams.
Common (1% to 10%): Vulvomycotic infectionFrequency not reported: Urinary tract infection, asymptomatic bacteriuria
Frequency not reported: Pneumonitis, pneumonia, pleural effusion, dyspneaPostmarketing reports: Interstitial pneumonia
Pneumonitis has been reported when this drug was administered via inhalation.
Postmarketing reports: Renal impairment/renal failure
Frequency not reported: Hypokalemia
Frequency not reported: Pyrexia, peripheral edema
Frequency not reported: Insomnia, anxiety
Bluish color
diarrhea
pain, tenderness, or swelling of the foot or leg
pale skin
troubled breathing with exertion
unusual bleeding or bruising
unusual tiredness or weakness
Abdominal or stomach cramps, pain, or tenderness
bloody urine
decreased frequency or amount of urine
fever
increased blood pressure
increased thirst
itching or pain of the vagina or genital area
loss of appetite
lower back or side pain
nausea or vomiting
sore mouth or tongue
swelling of the face, fingers, or lower legs
thick, white vaginal discharge with mild or no odor
troubled breathing
watery and severe diarrhea, which may also be bloody
weight gain
white patches in the mouth or on the tongue
Blistering, peeling, or loosening of the skin
chills
cough
difficulty with swallowing or sore throat
dizziness
fast heartbeat
itching
joint or muscle pain
loss of bladder control
muscle spasm or jerking of extremities
puffiness or swelling of the eyelids or around the eyes, face, lips, or tongue
red skin lesions, often with a purple center
red, irritated eyes
skin rash or hives
sores, ulcers, or white spots in the mouth or on the lips
sudden loss of consciousness
tightness in the chest
Headache